Physician profile
Olaf Js Samuelson
NPI 1013535988
$689.52
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.43 · 2021: $366 · 2022: $308.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $79.99 | 2022 | |
| Amgen INC. | $67.90 | 2021 | |
| Lilly USA, LLC | $63.00 | 2021-2022 | |
| Abbott Laboratories | $61.95 | 2021 | |
| Amarin Pharma, INC. | $56.49 | 2021 | |
| Alkermes, INC. | $55.30 | 2022 | |
| Novo Nordisk INC | $50.32 | 2021 | |
| Janssen Biotech, INC. | $40.30 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $33.59 | 2020-2022 | |
| Mylan Specialty L.P. | $32.91 | 2021 | |
| Mallinckrodt Hospital Products INC. | $30.15 | 2022 | |
| Abbvie INC. | $25.54 | 2021 | |
| Taiho Oncology, INC. | $20.75 | 2022 | |
| Dexcom, INC. | $18.14 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.03 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $17.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.27 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olaf Samuelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.